EndoChoice, Inc.

Based near Atlanta, Georgia, EndoChoice (NYSE: GI) focuses on the manufacturing and commercialization of technologies including endoscopic imaging systems, devices and infection control products, and pathology services for specialists treating a wide range of gastrointestinal conditions, including colon cancer. The Company was founded in 2008 and has rapidly developed a broad and innovative product portfolio, which includes the Full Spectrum Endoscopy System (Fuse®). EndoChoice, Fuse, and Full Spectrum Endoscopy are registered trademarks of EndoChoice, Inc.